top of page
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
- Sat, Jun 07
- Thu, Jun 12Adverse Reaction Identification and Management Considerations ~ CARVYKTI /Davio's Northern Italian Restaurant
- Thu, May 22
- Thu, May 15
- Tue, May 13
Search
Management Strategies forReducing the Risk of Recurrence in HER2+ Breast Cancer ~ March 23 @ 6:00PM
Join us for a virtual educational program to learn more about: • Current treatment landscape and unmet needs for patients with early...
Mar 8, 20211 min read
16 views
0 comments
Managing LYNPARZA: Efficacy and Safety of LYNPARZA Therapy ~ March 18th @ 6:15PM
Register Now Please join us for a virtual event Managing LYNPARZA: Efficacy and Safety of LYNPARZA Therapy and Adverse Reaction...
Mar 8, 20211 min read
15 views
0 comments
Gynecologic Oncology and Sexual Health An Intimate Conversation ~ March 24th 6:30PM
Click the image below to RSVP and view the webex. Please also email Jodi Perriello @ jodi.x.perriello@gsk.com.
Mar 4, 20211 min read
24 views
0 comments
Biosimilars in Value Based Oncology Care ~ March 11th @ Grill 23 Bar and Grill
March 11th ~ 6:00PM Presentations begins at 6:30PM Presented by Jeff Nemeth, Pharm D, Englewood Hospital and Medical Center If...
Mar 2, 20211 min read
45 views
0 comments
Moving Beyond Surviving ~ April 26th, 2021
Moving Beyond Surviving: How to Embrace the Challenges and Find Joy in Your Leadership Role On Demand Webinar As a nurse new to...
Mar 2, 20212 min read
61 views
0 comments
The Importance of the Supportive Care Team in Treating Multiple Myeloma ~ March 4th, 2021
KaryoTalk presents in support of Multiple Myeloma Awareness Month, The Importance of the Supportive Care Team in Treating Multiple...
Mar 2, 20211 min read
21 views
0 comments
COHERUS Academy for Biosimilars ~ New Program
Objectives: o To review the clinical profile of UDENYCA®, including mechanism of action, efficacy, safety, indications, and dosing o To...
Feb 13, 20211 min read
25 views
0 comments
A discussion and Q&A regarding polycythemia vera ~ SAVE THE DATE ~ 3/25/21
Register at http://bit.ly/PharmaEssentiaBroadcast
Feb 13, 20211 min read
28 views
0 comments
Science for a Better Life ~ Colorectal Cancer - Disease Overview ~ 4/28/21
BAYER cordially invites you to attend the following Virtual non-CME Educational Opportunity: STIVARGA and NEXAVAR 2 Colorectal Cancer -...
Feb 13, 20211 min read
12 views
0 comments
Finding Compassion Satisfaction and Resilience during the COVID 19 Pandemic
Moderated by Nellee Fine, RN, MSN, AOCN and Cynthia Medeiros, LICSW The panelists include Dana Cameron, RN, BSN, OCN, Nurse Navigator,...
Feb 8, 20211 min read
49 views
0 comments
TAGRISSO in the Treatment of Resectable NSCLC with EGFR Exon 19 Deletions or Exon 21 L858R Mutations
This 60-minute program includes a presentation and a question-and-answer session about the adjuvant treatment of resectable EGFR...
Jan 30, 20211 min read
25 views
0 comments
A program on an FDA-approved treatment option metastatic Urothelial Carcinoma ~ PADCEV
PRESENTED BY Daniel Landau, MD Section Chief Hematology/Oncology Orlando Health UF Health Cancer Center Orlando, FL DATE AND TIME...
Jan 30, 20211 min read
17 views
0 comments
Patient Access Services and Reimbursement Overview
OBJECTIVES: - Describe the patient access services available through Coherus COMPLETE. - Explain coding and the coverage and...
Jan 27, 20211 min read
11 views
0 comments
Impact of Long-Term Echelon-1 Data in Stage III/IV CHL
Thursday, January 21st, 2021 6:30PM and 9:00PM Sponsored by Seagen For more information visit the following link:...
Jan 15, 20211 min read
14 views
0 comments
TAZVERIK (tazemetostat) ~ Relapsed or Refractory Follicular Lymphoma
Don't miss this new upcoming event! Click image above to register! Event flyer attached below.
Jan 6, 20211 min read
19 views
0 comments
TAZVERIK ~ Now Approved ~ Virtual Talk Thursday, 12/10/20 @ 5:00PM
TAZVERIK™ (tazemetostat) is indicated for the treatment of:∙Adult patients with relapsed or refractory follicular lymphoma whose tumors...
Dec 5, 20201 min read
6 views
0 comments
Nov 19, 20200 min read
10 views
0 comments
A Treatment Option for the Management of Patients With First-Line NSCLC & Metastatic Melanoma
A Treatment Option for the Management of Certain Patients with First-Line NSCLC & Unresectable Metastatic Melanoma VIRTUAL EVENT Click on...
Nov 2, 20201 min read
22 views
0 comments
BONS Members ONLY ~ New Evidence in First-Line AML & Exploring Outcomes
BONS Members ONLY! Click date links below to REGISTER through Boston ONS. Tuesday, November 10th 5PM Tuesday, November 10th 8PM Thursday,...
Oct 28, 20202 min read
27 views
0 comments
Combining the HER2+ Breast Cancer Antibodies You Know in One Fixed-Dose Subcutaneous Injection ~ NEW
PROGRAM OBJECTIVES: Provide product overview including indication, important safety information, dosing, and administration Review...
Oct 28, 20201 min read
21 views
0 comments
bottom of page